What is Advanced Oncotherapy?
Advanced Oncotherapy specializes in the development and provision of proton therapy systems, a cutting-edge approach to cancer treatment that harnesses the precision of particle beams. Their core innovation lies in the "LIGHT" (Linac Image Guided Hadron Technology) system, a proprietary proton accelerator that is significantly more compact and cost-effective than traditional machines. This technology enables healthcare providers to offer cancer treatment with enhanced precision, leading to better patient outcomes and reduced treatment-related side effects. The company's strategic focus is on making this advanced medical technology accessible to a wider range of healthcare facilities.
How much funding has Advanced Oncotherapy raised?
Advanced Oncotherapy has raised a total of $23.3M across 5 funding rounds:
Multiple Rounds
$13.3M
Share Placement
$10M
Debt (2017): $3.7M with participation from Blackfinch Investments
Debt (2017): $2.6M led by Blackfinch Investment.
Debt (2017): $1.9M supported by Blackfinch Investment.
Debt (2017): $5.1M, investors not publicly disclosed
Share Placement (2020): $10M backed by SI Capital Ltd
Key Investors in Advanced Oncotherapy
Blackfinch Investments
Blackfinch Investments is an investment firm that has provided debt financing to Advanced Oncotherapy, indicating a focus on supporting the company's operational and developmental capital needs.
SI Capital Ltd
SI Capital Ltd participated in a share placement, suggesting an interest in the equity growth and long-term potential of Advanced Oncotherapy's innovative medical technology.
What's next for Advanced Oncotherapy?
With the recent major strategic investment, Advanced Oncotherapy is poised for significant growth and expansion. The company is likely to accelerate the development and deployment of its LIGHT proton therapy systems, aiming to capture a larger share of the oncology market. This capital injection will probably support further research and development, enhance manufacturing capabilities, and bolster sales and marketing efforts to reach new healthcare partners globally. The strategic nature of this financing suggests a focus on scaling operations and solidifying its position as a leader in innovative cancer treatment technology.
See full Advanced Oncotherapy company page
